Alyeska Investment Group’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-142,857
Closed -$714K 600
2021
Q4
$714K Buy
+142,857
New +$714K 0.01% 549
2014
Q1
Sell
-73,970
Closed -$1.02M 291
2013
Q4
$1.02M Sell
73,970
-67,016
-48% -$920K 0.04% 225
2013
Q3
$2.66M Sell
140,986
-3,514
-2% -$66.3K 0.11% 160
2013
Q2
$2.04M Buy
+144,500
New +$2.04M 0.1% 164